Treatment outcomes for severe leaking tricuspid valve
Part of Heart & circulation clinical trials.
This study looks at what happens to adults with moderate-to-severe or severe tricuspid valve “leaking” after different treatment types, such as catheter-based or surgery. It may help doctors understand which approach works best for people with severe valve leakage and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your tricuspid valve leak is the main problem (no major left-side valve disease, like significant mitral regurgitation)
- Your tricuspid valve leak is moderate to severe or severe
- Your leak is considered “functional” (often related to heart strain or other changes, not from a primary valve defect)
- You have not had any prior tricuspid valve procedure
- You do not have a congenital (born-with) valve problem, or other valve diseases that go along with this issue
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests how well a new catheter-based valve system works for people with severe (or worse) tricuspid valve leaking who still have symptoms despite medicines. It aims to improve outcomes by treating the leaking valve without open-heart surgery, if your heart structure and overall health fit the study.
This study records patients who get a catheter-based repair for a severely leaky tricuspid heart valve. It helps doctors and researchers learn how these treatments work in real-world care.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.